The Gamaleya National Research Center of Epidemiology and Microbiology of the Ministry of Health of the Russian Federation and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announced that the Sputnik V vaccine demonstrated efficacy of 97.6%, based on the analysis of data on the infection rate of...
Full ArticleForeign Experts Assess Benefits Of Russia’s Sputnik V Coronavirus Vaccine – Analysis
Eurasia Review
0 shares
1 views
You might like
Related news coverage
Russia Making Headway In Mobilizing Domestic Resources In Fight Against Coronavirus Pandemic – OpEd
With a strong structured plan and that includes President Vladimir Putin weekly meetings with regional governors and related..
Eurasia Review
EU report takes aim at Russia over vaccine fake news
BRUSSELS (AP) — Russia has launched a major campaign using ministries, companies and pro-Kremlin media to promote the Sputnik V..
SeattlePI.com